Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FSFRT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,761
Award facts
- Contract value 100% obligated
- $31,760.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $31,760.69 delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose in 2ml prefilled pen format, with an ultimate completion date of September 24, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a maximum value of $999,999,999 and extends through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare systems and other federal customers worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency requirements and military healthcare programs. The company's federal contract portfolio demonstrates consistent capability to deliver specialized pharmaceuticals across multiple therapeutic domains through competitively awarded delivery orders. All reviewed contract awards with this vendor have involved non-set-aside competitive procurements with firm fixed pricing, reflecting AmerisourceBergen's established position within the federal supply chain. The DLA is planning subsequent generations of Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, indicating continued strategic reliance on qualified pharmaceutical distributors like AmerisourceBergen to meet military and federal healthcare supply requirements.
Quick answers
Who was awarded contract SPE2DB25FSFRT?
SPE2DB25FSFRT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FSFRT worth?
The government has obligated $31,761 on SPE2DB25FSFRT.
Is contract SPE2DB25FSFRT an order under another contract?
Yes. SPE2DB25FSFRT is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FSFRT competed?
The extent of competition for SPE2DB25FSFRT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award